Colossal Biosciences, the biotech startup known for its ambitious efforts to revive extinct species like the woolly mammoth and Tasmanian tiger, is turning its attention to a more immediate crisis - ...

Colossal Biosciences shared a progress update on the world's first new dire wolves — Romulus, Remus, and Khaleesi — since the species went extinct Courtesy of Colossal Biosciences Colossal Biosciences ...

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...

Those cute dire wolves are forming a pack. If you remember, Colossal Biosciences, the company seeking to bring back the woolly mammoth, revealed in April 2025 it had successfully birthed a trio of ...

Their names are Romulus, Remus and Khaleesi, and they’re the first dire wolves to walk the Earth in over 10,000 years — or so one biotech company and a flurry of recent headlines say. On April 7, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new company, called ...

The cloning industry is contracting—ironically, perhaps. On Tuesday, Colossal Biosciences announced that it has acquired ViaGen Pets and Equine, an animal cloning firm, marking Colossal’s first ...

ViaGen has successfully cloned endangered species like Przewalski’s horses. Elizabeth Arellano Photography/Courtesy Colossal Biosciences However, Colossal CEO Ben Lamm insists the move wasn’t ...